Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions.

Temkin SM, Mallen A, Bellavance E, Rubinsak L, Wenham RM.

Cancer. 2018 Dec 20. doi: 10.1002/cncr.31911. [Epub ahead of print] Review.

PMID:
30570740
2.

Menopausal hormone therapy and breast cancer.

Santen RJ.

J Steroid Biochem Mol Biol. 2014 Jul;142:52-61. doi: 10.1016/j.jsbmb.2013.06.010. Epub 2013 Jul 16.

PMID:
23871991
3.

Menopausal hormone therapy in cancer survivors: A narrative review of the literature.

Kuhle CL, Kapoor E, Sood R, Thielen JM, Jatoi A, Faubion SS.

Maturitas. 2016 Oct;92:86-96. doi: 10.1016/j.maturitas.2016.07.018. Epub 2016 Jul 27. Review.

PMID:
27621244
4.

Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations.

Velentzis LS, Salagame U, Canfell K.

BMC Health Serv Res. 2017 May 5;17(1):326. doi: 10.1186/s12913-017-2227-y. Review.

6.

Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Pfeiffer RM, Park Y, Kreimer AR, Lacey JV Jr, Pee D, Greenlee RT, Buys SS, Hollenbeck A, Rosner B, Gail MH, Hartge P.

PLoS Med. 2013;10(7):e1001492. doi: 10.1371/journal.pmed.1001492. Epub 2013 Jul 30.

7.

Hormone replacement therapy and cancer.

[No authors listed]

Gynecol Endocrinol. 2001 Dec;15(6):453-65. Review.

PMID:
11826770
8.

Cancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.

Jordan SJ, Wilson LF, Nagle CM, Green AC, Olsen CM, Bain CJ, Pandeya N, Whiteman DC, Webb PM.

Aust N Z J Public Health. 2015 Oct;39(5):434-40. doi: 10.1111/1753-6405.12451.

9.

Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.

DeBono NL, Robinson WR, Lund JL, Tse CK, Moorman PG, Olshan AF, Troester MA.

J Womens Health (Larchmt). 2018 Mar;27(3):377-386. doi: 10.1089/jwh.2016.6063. Epub 2017 Jun 1.

PMID:
28570827
10.

Breast cancer risk in relation to the interval between menopause and starting hormone therapy.

Beral V, Reeves G, Bull D, Green J; Million Women Study Collaborators.

J Natl Cancer Inst. 2011 Feb 16;103(4):296-305. doi: 10.1093/jnci/djq527. Epub 2011 Jan 28.

11.

Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.

Davey DA.

Womens Health (Lond). 2012 Mar;8(2):169-89. doi: 10.2217/whe.12.1. Review.

PMID:
22375720
12.

Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.

Lacey JV Jr, Brinton LA, Leitzmann MF, Mouw T, Hollenbeck A, Schatzkin A, Hartge P.

J Natl Cancer Inst. 2006 Oct 4;98(19):1397-405.

PMID:
17018786
13.

Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States.

Yang HP, Anderson WF, Rosenberg PS, Trabert B, Gierach GL, Wentzensen N, Cronin KA, Sherman ME.

J Clin Oncol. 2013 Jun 10;31(17):2146-51. doi: 10.1200/JCO.2012.45.5758. Epub 2013 May 6.

14.

Menopausal hormone therapy and cancer risk: An overestimated risk?

Simin J, Tamimi R, Lagergren J, Adami HO, Brusselaers N.

Eur J Cancer. 2017 Oct;84:60-68. doi: 10.1016/j.ejca.2017.07.012. Epub 2017 Aug 4.

PMID:
28783542
15.

Prescribing menopausal hormone therapy: an evidence-based approach.

Sood R, Faubion SS, Kuhle CL, Thielen JM, Shuster LT.

Int J Womens Health. 2014 Jan 11;6:47-57. doi: 10.2147/IJWH.S38342. eCollection 2014. Review.

17.

Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.

Rosenberg LU, Magnusson C, Lindström E, Wedrén S, Hall P, Dickman PW.

Breast Cancer Res. 2006;8(1):R11. Epub 2006 Feb 17.

18.

Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.

Cordina-Duverger E, Truong T, Anger A, Sanchez M, Arveux P, Kerbrat P, Guénel P.

PLoS One. 2013 Nov 1;8(11):e78016. doi: 10.1371/journal.pone.0078016. eCollection 2013.

19.

Progesterone or progestin as menopausal ovarian hormone therapy: recent physiology-based clinical evidence.

Prior JC.

Curr Opin Endocrinol Diabetes Obes. 2015 Dec;22(6):495-501. doi: 10.1097/MED.0000000000000205.

PMID:
26512775
20.

Should we abstain from treating women with endometriosis using menopausal hormone therapy, for fear of an increased ovarian cancer risk?

Rozenberg S, Antoine C, Vandromme J, Fastrez M.

Climacteric. 2015;18(4):448-52. doi: 10.3109/13697137.2015.1041905. Epub 2015 May 11.

PMID:
25958744

Supplemental Content

Support Center